share_log
Benzinga ·  Mar 12 11:32
Theratechnologies Presented Data From A Real-world, Observational, Registry Study Demonstrating The Efficacy And Safety Of Ibalizumab In Reducing HIV RNA To Undetectable Levels In Heavily Treatment-experienced Patients With Multidrug Resistant HIV
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Write a comment